Pharma BD Deal Intelligence

Endo Pharmaceuticals Holdings, Inc. / Indevus Pharmaceuticals, Inc.

2009 · Acquisition/Merger · $370M · Complete

Announcement Sentiment
88
Strongly positive

Announced Jan 5, 2009; closed Feb 2009. $370M cash + up to $267M milestones. Urology/endo/oncology (Vantas, Valstar). Source: SEC 8-K, Fierce Biotech.

Key facts

See the full interactive analysis, sources & comparables →